Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Surmodics, Inc.

Surmodics, Inc. (SRDX) Stock Overview

Explore Surmodics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

SRDX●NASDAQ
HealthcareMedical - Devices
$42.98
$0.00(0.00%)
U.S. Market opens in 3h 6m

Surmodics, Inc. (SRDX)

Meyka AI Score

Z

Key Financials

Market Cap614.5M
P/E Ratio-58.88
EPS (TTM)$-1.24
ROE-0.10%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$34.52

SRDX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Surmodics, Inc. (NASDAQ: SRDX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Surmodics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of SRDX on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $34.52 for the NASDAQ listing.

Key metrics behind Surmodics, Inc.'s NASDAQ-traded stock include a P/E ratio of -58.88 and a market capitalization of 614.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of SRDX on the NASDAQ.

Price Performance (NASDAQ: SRDX)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
39.45%
6-Month Change
48.67%
Year-to-Date (YTD) Change
8.32%
1-Year Change
8.34%
3-Year Change
35.28%
5-Year Change
7.48%
All-Time (Max) Change
957.97%

Contact Information

https://www.surmodics.com
952 500 7000
9924 West 74th Street, Eden Prairie, MN, 55344-3523

Company Facts

3,890 Employees
IPO DateMar 4, 1998
CountryUS

Frequently Asked Questions